Enrique Zudaire
Senior Vice President, Translational Sciences & Therapeutics Discovery Caribou Biosciences
Enrique Zudaire, Ph.D. is Senior Vice President of Translational Sciences and Therapeutics Discovery at Caribou Biosciences, where he leads efforts to advance CAR-T cell therapy programs into clinical development. He brings deep expertise in cancer biology, immunology, and therapeutic discovery and regularly represents Caribou at industry conferences. Dr. Zudaire holds a Ph.D. from the University of Navarra and has held senior scientific leadership roles focused on translational research and discovery in oncology and immunotherapy.
Seminars
Tuesday 15th September 2026
Utilizing Targeted Gene Editing to Engineer Durable T-Cell Therapies
11:30 am
- Identifying the biological process behind T-cell downregulation
- Identifying and targeting negative regulators of T-cell function to disrupt biological downregulation pathways and preserve potency
- Applying gene editing strategies to intrinsically enhance T-cell durability by preventing functional exhaustion and loss of therapeutic activity
